Loading...
Molecular Therapeutics in Development for Epidermolysis Bullosa: Update 2020
Epidermolysis bullosa (EB) is a group of rare genetic disorders for which significant progress has been achieved in the development of molecular therapies in the last few decades. Such therapies require knowledge of mutant genes and specific mutations, some of them being allele specific. A relativel...
Na minha lista:
| Udgivet i: | Mol Diagn Ther |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer International Publishing
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7264085/ https://ncbi.nlm.nih.gov/pubmed/32328988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40291-020-00466-7 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|